Faculty of dentistry Mansoura University
Al Mansurah, Egypt
NCT Number: NCT07319884
aim of study: is to compare the effect of the fluoride varnish application on the prevention of white spot lesions (WSLs) during clear aligner therapy
Design Details: Each participant will have one side of the mouth assigned to the fluoride varnish intervention, while the contralateral side will serve as the control without fluoride varnish.
Outcomes:
Primary outcome: Incidence and Severity of White Spot Lesions Measured before and after six months using Laser fluorescence (DIAGNOdent)
Secondary Outcome:
Periodontal Ligament (PDL) Health using pocket Depth Index (PDI) Gingival Bleeding and Inflammation using bleeding on Probing Index (BOP)
This study is active but is not currently recruiting participants.
Notify Me16 year–24 year
All sexes
Interventional
Not applicable
Al Mansurah, Egypt
aim of study: is to compare the effect of the fluoride varnish application on the prevention of white spot lesions (WSLs) during clear aligner therapy in comparison to a split mouth-controlled group
Sample size calculation:
The sample size was calculated using G* power software (version3.1.9.7) and was designed to have a power of 85% assuming a type I statistical error of 5% and a one tailed statistical test with an effect size f= 0.7730012 based on the study of Najafi et al. The means and standard deviation of the DIAGNOdent score of the varnish and control groups after six months were 1.23 ±0.45 and 1.78±0.90. The calculated sample size will be 25 patients. The sample size will be increased to include 30 patients to avoid any drop out.
Material and methods:
Intervention Group (Test Side):
Control Group (Control Side):
Outcome Measures:
Primary Outcome:
Secondary Outcome:
Randomization and Application Site
To minimize bias, the side of the maxillary arch (right or left upper side) for fluoride varnish application was randomly assigned for each of the patients using a computer-generated randomization sequence
Inclusion and Exclusion Criteria Eligible participants were patients aged 16-24 years, representing the typical demographic for clear aligner therapy and ensuring biological consistency in terms of tooth development and orthodontic response. All participants were required to be in good general and oral health to minimize confounding factors related to systemic or oral disease, to present with mild dental crowding in each arch to standardize treatment complexity, and to have full eruption of all permanent teeth excluding third molars to allow consistent varnish application and assessment. Patients were excluded if they had a known allergy or hypersensitivity to fluoride-containing materials, systemic conditions that could affect tooth movement (such as diabetes or bone metabolism disorders), cleft lip and/or palate or other craniofacial anomalies, a history of previous orthodontic treatment, or clinical evidence of dental fluorosis, as these factors could alter enamel characteristics, orthodontic response, or lesion assessment and thereby introduce bias into the study outcomes.
Duration of the study:
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Application of fluoride varnish at the cervical third of labial surface or around the attachment if present
No fluoride varnish application at the cervical third of the labial surface or around the attachment if present
Time frame: Six months
Incidence and Severity of White Spot Lesions Measured before and after six months using Laser fluorescence (DIAGNOdent)
Time frame: Six moths
Health using pocket Depth Index (PDI)
Time frame: Six months
using bleeding on Probing Index (BOP)
Mansoura University
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07602660
White Spot Lesion
View Trial DetailsNCT05989750
Gingival Diseases, Gingivitis
Geneva, Canton of Geneva, Switzerland
View Trial DetailsNCT05738369
White Spot Lesion
Irbid, Jordan
View Trial DetailsNCT06166849
White Spot Lesion
Cluj-Napoca, Romania
View Trial Details